ArticleScientific reports2024

Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder.

Chanchan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.